May 30, 2018 - Names on the move ahead of the open.
May 30, 2018 - Novo Nordisk's (NVO) oral formulation of Ozempic acts better in lowering blood sugar levels in adults with type II diabetes than Eli Lilly's Jardiance, in the second phase IIIa study, PIONEER 2.
May 24, 2018 - Gilead took net gain safer May dividend Healthcare WallStar honors. Its 27.4% net gain was 23% better than Sanofi's, and 32% ahead of AmerisourceBergen's result per analyst targets of 5/22/18.22 of 31
May 21, 2018 - Investing in quality stocks can be remarkably profitable in the long term.Quality can be hard to define, but some quantitative indicators are clear signs of underlying fundamental quality.Introducing
May 18, 2018 - Top Research Reports for Walmart, AT&T & Novo Nordisk
May 16, 2018 - Jeremy Grantham Buys Facebook, Novo Nordisk, Stocks: FB,NVO,VIPS,BG,MGA,DHR,SNY,FOXA, Jeremy Grantham, release date:May 16, 2018
May 14, 2018 - Provention Bio wants to raise $40 - $50 million in a 'best efforts' U.S. IPO.The firm is advancing a varied mid- to late-stage pipeline of drug candidates.PRVB's enviable partnerships are a plus, but
May 10, 2018 - NVO reported a positive quarter in local currencies, a negative quarter in Danish kroner, and currency hedging gains.More important to me is the big picture at the company, with a structural corporate
May 08, 2018 - I recommended NVO for purchase in January, 2017.This analysis revisits the major pharmaceutical group looking specifically at earnings quality, earnings growth and valuation.The situation that underpi
May 08, 2018 - Emisphere's partner in oral GLP-1 development, Novo Nordisk, released outstanding PIONEER 1 phase-3 trial results and these portend excellent future PIONEER results.Novo's statements at their 1Q18 mee